Metraipolis › archive › dc_a24ca0da3632

Refining the clinical utility of [177Lu]Lu/[225Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancer — Europe PMC PMID:41174098

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41174098
DOI
10.1007/s00259-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-08T20:40:03.393Z
SHA-256 of the archived text
36039485bf0a3d45631b1cd4cb35243d0c40bda5ecddbfc508a7854eefab89ed
Stable URL of this page
https://metraipolis.com/documento/dc_a24ca0da3632

How to cite

Refining the clinical utility of [177Lu]Lu/[225Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancer — Europe PMC PMID:41174098 — Europe PMC (en), https://europepmc.org/article/MED/41174098 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a24ca0da3632 (Metraipolis archive dc_a24ca0da3632, sha256 36039485bf0a3d45631b1cd4cb35243d0c40bda5ecddbfc508a7854eefab89ed)
BibTeX
@misc{dca24ca0da3632,
  title = {Refining the clinical utility of [177Lu]Lu/[225Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancer — Europe PMC PMID:41174098},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41174098},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a24ca0da3632; sha256 36039485bf0a3d45631b1cd4cb35243d0c40bda5ecddbfc508a7854eefab89ed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41174098. Agents can read the archived copy with the MCP tool read_document.